UBS Group’s Concord Medical Services CCM Stock Holding History
Bought
Maintained
Sold
Other funds holding CCM
UBS Group's CCM Position: Q3 2026 in Review
UBS Group reduced its Concord Medical Services (CCM) stake by 6% in Q3 2026, selling an estimated $132 and leaving 470 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #10244.
UBS Group first reported a position in CCM in Q2 2013 and has held it in 47 quarters since. The position peaked at $389K in Q2 2025. 9 funds tracked by Wall St. Rank hold CCM as of Q3 2026.
- UBS Group held 470 shares of Concord Medical Services worth $1.48K as of Q3 2026.
- UBS Group sold 30 Concord Medical Services shares in Q3 2026, an estimated $132.
- Concord Medical Services made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10244 holding.
- UBS Group first reported a position in Concord Medical Services in Q2 2013 and has held it in 47 quarters since.
- UBS Group's Concord Medical Services position peaked at $389K in Q2 2025.
- 9 funds tracked by Wall St. Rank held Concord Medical Services as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.